GlassScriptPhysician profile
Michael Fano
NPI 1740394204
$6,663.90
in general payments reported to CMS, 2019-2025
20 companies · $1,162 in 2025
The $1,162 reported for 2025 was more than what 87% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,920 · 2022: $1,047 · 2023: $1,172 · 2024: $1,363 · 2025: $1,162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,698.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,697.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $1,486.07 | 2021-2025 | Biktarvy, Yeztugo |
| Viiv Healthcare Company | $1,333.41 | 2021-2025 | Dovato, Cabenuva, Apretude |
| Janssen Biotech, INC. | $1,057.00 | 2021-2023 | Symtuza |
| Neurocrine Biosciences, INC. | $590.93 | 2021-2024 | Ingrezza |
| Abbvie INC. | $514.49 | 2021-2023 | |
| Teva Pharmaceuticals USA, INC. | $489.32 | 2021-2025 | Austedo, Austedo Xr, Uzedy |
| Janssen Products, LP | $375.00 | 2021-2023 | Symtuza |
| Alkermes, INC. | $208.93 | 2021-2024 | Aristada, Lybalvi |
| Merck Sharp & Dohme LLC | $170.82 | 2021-2025 | Gardasil 9, Capvaxive, Pifeltro |
| Otsuka America Pharmaceutical, INC. | $94.84 | 2023-2025 | Abilify Maintena, Abilify Asimtufii, Rexulti |
| Kyowa Kirin, INC. | $80.98 | 2022 | |
| Lundbeck LLC | $57.38 | 2022-2025 | Abilify Maintena |
| Emd Serono, INC. | $46.45 | 2024-2025 | |
| Axsome Therapeutics, INC. | $34.02 | 2025 | Auvelity |
| Lilly USA, LLC | $30.57 | 2025 | Zepbound, Mounjaro |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $24.60 | 2021 | |
| Exact Sciences Corporation | $22.62 | 2023 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $16.64 | 2022 | |
| Dynavax Technologies Corporation | $16.07 | 2021 | |
| Orexo US, INC. | $13.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Fano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.